Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Bambusa Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focusing on developing long-acting precision bispecific antibodies designed for care in immunology and inflammation (I&I) and improving patient quality of life. It uses third-party, advanced antibody engineering to create long-acting bispecific antibodies that combine clinically and commercially validated biologic pathways into a single molecule formulated for high-concentration subcutaneous (SubQ) delivery. Its lead product candidate, BBT001, is a next-generation, long-acting bispecific antibody targeting two clinically and commercially validated pathways, interleukin-4 receptor alpha and interleukin-31, is designed to simultaneously address core Type 2 inflammation and chronic itch, the two defining burdens of atopic dermatitis (AD) and other inflammatory skin diseases. BBT001 is engineered using validated half-life extension technology with the goal of enabling extended dosing intervals.
Find out what a historical investment in Bambusa Therapeutics would be worth today using our BBTX stock calculator.
Buying BBTX shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Bambusa Therapeutics in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in BBTX
What is the ticker symbol of Bambusa Therapeutics?
The ticker symbol for Bambusa Therapeutics is BBTX.
How much is one share of BBTX?
One share of BBTX is valued at $15.55 as of 20 November 2026.
What is the market capitalisation of Bambusa Therapeutics BBTX?
As of 20 November 2026 Bambusa Therapeutics has a market cap of $809.98M.
What is the 52-week high for Bambusa Therapeutics stock?
The Bambusa Therapeutics 52-week high stock price is $17.65.
What is the 52-week low for Bambusa Therapeutics stock?
The Bambusa Therapeutics 52-week low stock price is $13.60.
Can I buy BBTX shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy BBTX shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in BBTX on Stake
Buy BBTX from US$3 brokerage
Invest in 11,000+ U.S. stocks and ETFs
Own a slice of BBTX from only US$10 with fractional shares